VJOncology is committed to improving our service to you

ESMO 2017 | The current state of drug development against sarcomas

VJOncology is committed to improving our service to you

Robin Jones

Robin Jones, BSc, MB BS, MRCP, MD (Res), from The Royal Marsden NHS Foundation Trust, London, UK talks to us about the sessions presented at the 2017 European Society for Medical Oncology (ESMO) conference which focused on the current state of research into sarcoma treatments. Dr Jones explains the main message he took away from these presentations, and talks us through some of the ongoing work into sarcoma treatment, including trials to investigate the agents BLU-285 (NCT02508532), DCC-2618 (NCT02571036) and crenolanib (NCT02847429). This interview was recorded at ESMO 2017 in Madrid, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter